[4,5-dibromo-9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium chloride

C28H29Br2ClN2O3 — CID 10168278

IUPAC[4,5-dibromo-9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium chloride
SMILESCCNc1c(C)cc2c(-c3ccccc3C(=O)OCC)c3cc(C)/c(=[NH+]\CC)c(Br)c-3oc2c1Br.[Cl-]
InChIInChI=1S/C28H28Br2N2O3.ClH/c1-6-31-24-15(4)13-19-21(17-11-9-10-12-18(17)28(33)34-8-3)20-14-16(5)25(32-7-2)23(30)27(20)35-26(19)22(24)29;/h9-14,31H,6-8H2,1-5H3;1H/b32-25+;
InChIKeyWXUCHMJBBPEYJJ-MKRHLXOOSA-N
MW636.81 g/mol
LogP2.96
Rot. Bonds6

About [4,5-dibromo-9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium chloride

[4,5-dibromo-9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium chloride (PubChem CID 10168278) has the molecular formula C28H29Br2ClN2O3 and a molecular weight of 636.81 g/mol. Its IUPAC name is [4,5-dibromo-9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium chloride.

Molecular Properties

Compound Name[4,5-dibromo-9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium chloride
PubChem CID10168278
Molecular FormulaC28H29Br2ClN2O3
Molecular Weight636.81 g/mol
Exact Mass634.02
IUPAC Name[4,5-dibromo-9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium chloride
SMILESCCNc1c(C)cc2c(-c3ccccc3C(=O)OCC)c3cc(C)/c(=[NH+]\CC)c(Br)c-3oc2c1Br.[Cl-]
InChIInChI=1S/C28H28Br2N2O3.ClH/c1-6-31-24-15(4)13-19-21(17-11-9-10-12-18(17)28(33)34-8-3)20-14-16(5)25(32-7-2)23(30)27(20)35-26(19)22(24)29;/h9-14,31H,6-8H2,1-5H3;1H/b32-25+;
InChIKeyWXUCHMJBBPEYJJ-MKRHLXOOSA-N
XLogP2.96
TPSA65.44 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500636.81
LogP ≤ 52.96
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Analyze [4,5-dibromo-9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium chloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [4,5-dibromo-9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium chloride?
The IUPAC name of [4,5-dibromo-9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium chloride (CID 10168278) is [4,5-dibromo-9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium chloride.
What is the SMILES notation for [4,5-dibromo-9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium chloride?
The canonical SMILES for [4,5-dibromo-9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium chloride is CCNc1c(C)cc2c(-c3ccccc3C(=O)OCC)c3cc(C)/c(=[NH+]\CC)c(Br)c-3oc2c1Br.[Cl-].
What is the InChIKey of [4,5-dibromo-9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium chloride?
The InChIKey is WXUCHMJBBPEYJJ-MKRHLXOOSA-N. The full InChI is InChI=1S/C28H28Br2N2O3.ClH/c1-6-31-24-15(4)13-19-21(17-11-9-10-12-18(17)28(33)34-8-3)20-14-16(5)25(32-7-2)23(30)27(20)35-26(19)22(24)29;/h9-14,31H,6-8H2,1-5H3;1H/b32-25+;.
What are the key properties of [4,5-dibromo-9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium chloride?
[4,5-dibromo-9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium chloride has a molecular weight of 636.81 g/mol, XLogP of 2.96, 6 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for [4,5-dibromo-9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium chloride is sourced from PubChem (CID 10168278), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).